TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
IDL Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
28,875
|
24,589
|
16,649 |
Financial expenses |
9
|
4
|
1 |
Earnings before taxes |
-3,223
|
167
|
-9,261 |
EBITDA |
-2,491
|
2,196
|
-8,949 |
Total assets |
22,667
|
26,890
|
30,041 |
Current assets |
17,742
|
22,108
|
25,584 |
Current liabilities |
5,424
|
6,530
|
4,433 |
Equity capital |
17,180
|
20,299
|
25,542 |
- share capital |
16,943
|
16,856
|
18,341 |
Employees (average) |
23
|
20
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.8%
|
75.5%
|
85.0% |
Turnover per employee |
1,255
|
1,229
|
1,041 |
Profit as a percentage of turnover |
-11.2%
|
0.7%
|
-55.6% |
Return on assets (ROA) |
-14.2%
|
0.6%
|
-30.8% |
Current ratio |
327.1%
|
338.6%
|
577.1% |
Return on equity (ROE) |
-18.8%
|
0.8%
|
-36.3% |
Change turnover |
4,160
|
9,288
|
835 |
Change turnover % |
17%
|
61% | |
Chg. No. of employees |
3
|
4
|
-2 |
Chg. No. of employees % |
15%
|
25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.